McCain Tracey L
CIK: 0001683600
Associated companies
this person other insiders at KNSA
Transaction History
| KNSA | ▲ Buy | Option Exercise | 2,799 | — | 5/29/2026 | View on chart |
| KNSA | ▲ Buy | Option Exercise | 3,173 | — | 6/5/2025 | View on chart |
| KNSA | ▲ Buy | Option Exercise | 4,373 | — | 6/6/2024 | View on chart |
| KNSA | ▲ Buy | Option Exercise | 5,000 | — | 6/29/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Kiniksa Reports Strong Growth and Accelerating Earnings
Kiniksa Pharmaceuticals has reported earnings that are accelerating, supporting its growth narrative. Analysts note that the company’s performance shows little room for disappointment, reinforcing confidence in its business model. The company’s recent data underscores its position as a solid growth player in the pharmaceutical sector.
Kiniksa Reports Strong Growth and Accelerating Earnings. Kiniksa Pharmaceuticals has reported earnings that are accelerating, supporting its growth narrative. Analysts note that the company’s performance shows little room for disappointment, reinforcing confidence in its business model. The company’s recent data underscores its position as a solid growth player in the pharmaceutical sector.